Abstract |
A multidrug-resistant (MDR) clone of Plasmodium falciparum (C2A) from Thailand was adapted through serial passage to Aotus monkeys. During adaptation, the parasite showed resistance to a single 20 or 40 mg/kg oral dose of mefloquine (MQ). Infection was only cured when MQ was administered orally at 40 mg/kg once in combination with intravenous artesunic acid at 20 mg/kg for 3 days. Similarly, the parasite clone was found to be resistant to quinine, failing at 20 mg/kg orally for 5 days in combination with an experimental dihydrofolate reductase (DHFR) inhibitor (WR297608) at 10, 20, or 40 mg/kg orally for 3 days, and with atovaquone/proguanil at 25 mg/kg for 3 days. This new model will allow in vivo testing of new antimalarial compounds or their combinations against a currently circulating MDR P. falciparum strain.
|
Authors | Nicanor Obaldía 3rd, Wilbur Milhous, Dennis Kyle |
Journal | The American journal of tropical medicine and hygiene
(Am J Trop Med Hyg)
Vol. 81
Issue 4
Pg. 587-94
(Oct 2009)
ISSN: 1476-1645 [Electronic] United States |
PMID | 19815871
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
|
Topics |
- Adaptation, Physiological
- Animals
- Antimalarials
(pharmacology)
- Aotidae
- Drug Resistance, Multiple
- Female
- Malaria, Falciparum
(parasitology)
- Male
- Parasitemia
- Plasmodium falciparum
(drug effects, physiology)
- Thailand
- Time Factors
|